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Introduction1
Poxviruses, of which vaccinia virus is the best studied
representative, are complex, DNA-containing viruses
that replicate in the cytoplasm of the infected cell.
During the infection cycle viral gene expression takes
place in successive steps, namely early, intermediate
and late. This temporal regulation is achieved by modi-
f ication of the virally encoded RNA polymerase by
transcription factors.
Vaccinia virus infection is known to induce a dramatic
«shut-off» in the synthesis of cellular proteins. To date,
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Abstract
In this study, we examined the role of the nucleotides flanking AUG initiator codons in modulating translation of
vaccinia virus genes. First, the sequence around initiation codons in the genomic sequence of vaccinia was analyzed.
A preference for A in position –3 and for A or G in position +4, relative to the A of the initiator AUG codon was noted.
These results are in broad agreement with known optimal consensus for the translation of eukaryotic mRNAs.
Nucleotides –3 and +4, which are known to affect the efficiency of translation of cellular mRNAs over a 20-fold range,
were examined by site-directed mutagenesis and functional assays in the context of vaccinia-infected cells. A collection
of virus recombinants expressing β-Galactosidase (β-Gal) under the control of a strong promoter and containing all
possible nucleotide substitutions in those positions was generated. Quantitation of β-Gal mRNA and β-Gal activity
showed that the efficiency of translation was not affected significantly by nucleotide substitutions in positions –3 and
+4. Therefore, despite the high occurrence of purine nucleotides in those positions in vaccinia mRNAs, no effect of
those positions was noted in conditions where β-Gal was overexpressed.
Additional key words: β-galactosidase, poxviruses, site-directed mutagenesis, translation initiation.
Resumen
Contexto de AUG y traducción de mRNA en el virus vaccinia
En este estudio hemos examinado el papel de los nucleótidos próximos al AUG iniciador en la modulación de la tra-
ducción en genes del virus vaccinia. En primer lugar, hemos analizado la secuencia alrededor de los codones de ini-
ciación en la secuencia genómica de vaccinia. En este análisis se detectó una preferencia por A en la posición –3, y por
A ó G en la posición +4, relativa a la A en el codon de iniciación. Estos resultados coinciden en términos generales con
las secuencias conocidas para la traducción óptima de mRNAs eucarióticos. Los nucleótidos –3 y +4, que afectan a la
eficiencia de traducción de mRNAs celulares en un rango de hasta 20 veces, fueron examinados por mutagénesis diri-
gida y ensayos funcionales en el contexto de células infectadas por vaccinia. Hemos generado una colección de virus
recombinantes que expresan β-galactosidasa (β-Gal) bajo el control de un promotor fuerte, y conteniendo todas las po-
sibles sustituciones en esas posiciones. La cuantificación del mRNA de β-Gal, y de la actividad β-Gal, mostró que la
eficiencia de traducción no se alteraba significativamente por las sustituciones nucleotídicas en las posiciones –3 y +4.
Por tanto, a pesar de la alta frecuencia de nucleótidos de purina en esas posiciones en los mRNAs de vaccinia, no se de-
tectó efecto de dichas posiciones en condiciones en las que la β-Gal era sobreexpresada.
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several possibilities have been proposed to explain this
process. The relative abundance of viral mRNAs may
partially explain the lowered synthesis of cellular
proteins, since several hours after infection the rapid
mRNA turnover and inhibition of host RNA synthesis,
along with the rise of viral transcripts, lead to a predo-
minance of mRNAs of viral origin (Becker and Joklik,
1964; Sebring and Salzman, 1967; Boone and Moss,
1978; Cooper and Moss, 1979). In addition, a variety
of cellular proteins and RNAs have been implicated in
regulating the translation of viral versus cellular mRNAs.
For instance, small RNAs (Bablanian et al., 1978;
Bablanian et al., 1993; Cacoullos and Bablanian, 1993),
the surface tubules of the virus particle (Mbuy et al.,
1982), or the proteins F17R (Person-Fernández and
Beaud, 1986) and B1R (Beaud et al., 1994) have been
proposed as specific inhibitors of host protein synthesis.
An additional factor that might modulate translation
efficiency of mRNAs is the sequence context around
the initiation codon. The optimal context for translation
initiation in mammalian species is GCC(A/G)CCAUGG,
where AUG is the initiation codon (Kozak, 1986, 1997,
1999). Within this sequence, the –3 and +4 positions
are particularly important, influencing translation effi-
ciency up to 20 fold (Kozak, 1986). In this report we
present an analysis of the viral genome showing that
vaccinia virus genes follow Kozak’s rules, in particular
in the key positions –3 and +4. We studied the influence
of these positions in the translation efficiency of vaccinia
virus mRNAs, and show that of highly expressed viral
late messengers is not significantly affected by mutations
in those positions.
Material and Methods
Cells, viruses and plasmids
BSC-1 cells, obtained from the American Type Culture
Collection (ATCC CCL 26) and CV-1 cells were grown
in Eagle’s minimal essential medium (EMEM) (Bio-
whittaker) containing 5% fetal bovine serum. The cells
were maintained at 37°C in a 5% CO2 atmosphere. The
infection/transfection protocol, plaque purification and
virus amplif ications were carried out as previously
described (Lorenzo et al., 2004). Plasmid pRB20-Lz1
(Barcena and Blasco, 1998) is a derivative of pRB21
(Blasco and Moss, 1995) containing a functional F13L,
flanking sequences and the LacZ gene downstream of
a synthetic vaccinia early/late promoter. Oligonucleotides
were synthesized by Amersham Pharmacia Biotech.
Virus manipulations were carried out using standard
protocols (Earl and Moss, 1991).
Isolation of recombinant viruses
To introduce mutations in the –3 and +4 positions
with respect to the β-Galactosidase (β-Gal) initiator ATG,
two overlapping oligonucleotides, β-Gal D and β-Gal
I (see sequence below), with a mixture of four nucleotides
in the respective positions, were synthesized. Two
overlapping PCR products were then generated using
pRB20-Lz1 as the template. Left PCR fragment was
obtained with oligonucleotides HF1510 (5’-GGACAT 
GCTTATGTACGTAGAAGAAAA-3’) and β-Gal I 
(5’-GATNCATCTNGAGTTATTTATAT-3’), being N
ambiguous positions, and contained vaccinia recombi-
nation flank F13L gene, synthetic early/late promoter
and the sequence mutated around the initiator ATG.
The right PCR fragment was obtained with oligonu-
cleotides HF 3400 (5’-CGTTCT AAAGCTAGTGCTA 
TATCTCCC-3’) and β-Gal D (5’-ACTCNAGATGNAT 
CCCGTCGTT-3’) and contained the synthetic early/late
promoter, LacZ gene with the mutated sequence around
the initiator ATG and vaccinia recombination flank.
To generate recombinant viruses, CV-1 cells were
infected with vaccinia virus F13L deletion mutant
(vRB12) and subsequently transfected with the above
described PCR fragments. First, 1 × 106 CV-1 cells were
infected with vaccinia F13L deletion mutant vRB12
(Blasco and Moss, 1992) in fresh EMEM medium con-
taining 2% fetal calf serum, at a multiplicity of infection
(MOI) of 0.05 pfu cell-1. One hour post-infection (hpi),
cells were transfected with 1 µg of the PCR products
using 25 µL of Lipotaxi transfection reagent (Roche)
following the manufacturer’s instructions. At 3 days
post-infection (dpi), cells were scrapped, freeze-thawed
three times and sonicated. Serial dilutions of progeny
virus were used to infect BSC-1 monolayers in 6-well
plates that were maintained at 37°C for two days under
an agarose overlay. In addition to the use of F13L as a
selective marker (Blasco and Moss, 1995), β-Gal ex-
pressing, plaque-forming viruses were selected by virus
plaquing under an agarose overlay containing X-Gal
(5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside,
MBI Fermentas). After a 2-day incubation 100 µL of
40 mg mL-1 X-Gal in dimetil formamide (DMF), in
12 mL of semisolid medium was added and large blue
plaques were selected.
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Single-plaque virus isolates were expanded, and
their sequence around the β-Gal ATG was determined.
With this aim, a fragment containing the region of the
promoter-ATG was amplified from each virus isolate
by PCR using primers 5’-TTCGGCAAATTTCGCCG 
GAACCCATTA-3’ and 5’-GCGATTAAGTTGGGTA 
ACGCC-3’ and then sequenced. Single representatives
of the sixteen possibilities of nucleotides in the –3 and
+4 positions were finally selected and amplified.
β-Galactosidase assay
BSC-1 cells grown in 6-well plates were infected at
a MOI of 3 pfu cell-1. At 24 hpi cells were collected,
pelleted and incubated for 10 min in 400 µL of chilled
lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl,
2 mM EDTA, 1% NP40 and 1 mM PMSF) on ice.
β-Gal activity present in cell lysates was measured
using o-nitrophenyl β-D-galacto-pyranoside (ONPG)
(Sigma) as substrate. The reaction was started by mixing
10 µL of cell lysate, 90 µL of H2O and 100 µL of 0.6 mg
mL-1 ONPG dissolved in Z buffer (60 mM Na2HPO4-
7H2O, 40 mM NaH2PO4-H2O, 10 mM KCl, 1 mM MgSO4,
50 mM β-mercaptoethanol). Absorbance at 414 nm
was recorded at 5 min intervals until values reached
saturation. β-Gal activity was quantified by comparison
with known concentrations of commercial β-Gal (Sigma).
Northern blotting
BSC-1 cells grown in P100 plates were infected with
virus recombinants at a MOI of 3 pfu cell-1. At 24 hpi
the cells were scraped from the plastic surface, pelleted
and resuspended in 600 µL of RLT buffer (Qiagen)
containing 1% β-mercapethanol. Total RNA was ex-
tracted using the «Rneasy Mini Kit» (Qiagen) according
to the manufacturer’s instructions. RNA was resuspended
in DEPC water and the concentration was estimated
by measuring the absorbance at 260 nm.
For electrophoresis of RNA, 15 µg of RNA were
denatured in a buffer that contained 50% deionized
formamide, 6.5% formaldehyde, 20 mM MOPS [3-(N-
morpholino) propanesulfonic acid] pH 7, 8 mM sodium
acetate, 1 mM EDTA for 15 min at 65°C, and cooled
immediately on ice. After adding 2 µL of loading buffer
(1% bromophenol blue, 10% glycerol), the samples
were loaded in 1.2% agarose low EEO (Pronadisa) gel
containing 6% formaldehyde in MOPS buffer (20 mM
MOPS pH 7, 8 mM sodium acetate, 1 mM EDTA).
Electrophoresis was performed at 3-4 V cm-1 until the
bromophenol blue had migrated two-thirds of the
length of the gel. RNA was then transferred to Hybond-
N nylon membrane (Amersham Pharmacia Biotech)
following the method of  Sambrook et al. (1989).
The probes were labeled with DIG-dUTP with the
PCR DIG Labelling Mix (Roche) by the incorporation
of digoxigenin-11-dUTP in the polymerase chain
reaction. The probe was purified with «QIAquick PCR
Purification Kit» (Qiagen) and a dot blot method was
used to verify DIG-dUTP incorporation.
Prehybridization of the f ilters was carried out in
50% deionized formamide, 6X SSC (0.15 M NaCl,
15 mM Na citrate), 5X Denhardt’s solution (1% BSA,
1% ficoll 400, 1% polyvinylpyrrolidone), 0.1% SDS
and 100 µg mL-1 denatured salmon sperm DNA. Hybri-
dizations were performed in the same solution at 42-
45°C. The labelled probes were heated for 5 min at
100°C before addition to the filters in the prehybridization
solution. After hybridization, the membranes were
washed at low stringency in 2X SSC, 0.1% SDS RT
twice for 15 min and at high stringency in 0.5X SSC,
0.1% SDS at 68°C twice for 15 min. Hybridized probe
was detected using the digoxigenin system (Roche)
following the manufacturer’s instructions.
Quantitative PCR
Quantitative RT-PCR was performed on RNA samples
extracted by using the ABITaqMan One-Step RT-PCR
(Applied Biosystems) per manufacturer’s instructions.
Primers 5’-CGCTCATCGATAATTTCACCG-3’ and
5’-GGCTGAAGTTCAGATGTGCG -3’, which ampli-
fied a 122-nt segment of β-Gal gene were used at 5 µM.
Internal probe 5’-GGCAGGGTGAAACGCAGG-3’
labeled with the fluorophore FAM (5’-6’FAM/
3’-TAMRA) was synthesized by Applied Biosystems
and was used at 25 µM. The reaction was carried out
in an ABI Prism 7700 Sequence Detection System
thermal cycler. RT-PCR conditions were: RT at 48°C-
30 min, Hot Start at 95°C-10 min, followed by 50 cycles
of 95°C-15 s, and 60°C-1 min.
Results
Analysis of the ATG context in vaccinia 
virus genes
Vaccinia virus (strain WR) genomic sequence (Gen-
Bank accession number AY243312) contains 218 anno-
tated open reading frames (ORFs). The sequences
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flanking the initiator ATG codon in these sequences
were analyzed. For this analysis, 99 ORFs containing
the TAAAT sequence, characteristic of vaccinia late
promoters, in the 30 nt upstream of the start codon
were classified as late. The remaining 115 ORFs were
classif ied as early. In many late vaccinia genes, the
TAAAT element overlaps the ATG codon. Therefore,
to prevent bias in nucleotide occurrence due to the
presence of the TAAAT element, 58 ORFs containing
the sequence TAAATG (being the underlined ATG the
start codon) were excluded from the analysis.
Twelve nucleotide positions flanking the start
codons at the beginning of each ORF were analyzed.
The distribution of nucleotides in these positions
(Fig. 1) revealed that A was present in the –3 position
in 101 out of 160 (63%) ORFs analyzed. Similarly, G
was the most abundant nucleotide in the +4 position
(65 out of 160 ORFs, 41%). In addition, a high frequency
of A was noted in position +5 (76 out of 160 ORFs,
47%). Preference of C in position –1 was also found,
but exclusively in early promoters (37 out of 119 pro-
moters, 32%). Therefore, there is an overall agreement
to the Kozak consensus sequence (A/G)CCATGG. In
particular, key positions –3 and +4 conform to the
Kozak rules both in early and late vaccinia ORFs.
Isolation of recombinant vaccinia viruses
To study the influence of positions –3 and +4 with
respect to the translation start codon in the context of
a vaccinia virus-infected cell, a collection of recombinant
vaccinia viruses overexpressing β-Gal was isolated.
Sixteen different recombinant viruses containing all
the nucleotide combinations in positions –3 and +4
with respect to the initiation AUG codon of β-Gal gene
were isolated. Mutagenic PCR was used to introduce
the mutations, and subsequently a selection system
based on plaque formation, and β-Gal staining was
used to isolate the different recombinant viruses (Fig. 2).
Viruses were termed VV-β-Gal NN according to the
nucleotides present in the –3 and +4 positions. Thus,
VV-β-Gal GC would be the version containing the
sequence GAGATGC around the start codon of β-Gal
gene (see Table 1).
Effect of mutations on β-Galactosidase
mRNA levels
We first investigated if the mutated positions had
significant effects on the accumulation of LacZ trans-
cripts. With this aim, a northern blot analysis of total
RNA isolated from BSC-1 cells infected for 24 hours
with the different vaccinia virus recombinants was carried
out (Fig. 3). It is known that most late vaccinia transcripts
are heterogeneous in length, due to the lack of a defi-
ned 3’end (Cooper et al., 1981; Mahr and Roberts, 1984).
Thus, not surprisingly LacZ transcripts in late RNA
gave a smear in gels, revealing heterogeneity in length.
Similar amounts of LacZ mRNA were detected for the
different virus mutants, indicating that the mutations
introduced did not affect significantly the RNA levels.
This conclusion was conf irmed by measuring the
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Figure 1. Analysis of AUG context in vaccinia virus ORFs (Acc. No. AY243312). Vaccinia virus (strain WR) ORFs were classi-
fied according to the absence or presence of the TAAAT element into early and late, respectively. Histograms show the distribu-
tion of nucleotides in the six positions upstream (–6 to –1) or downstream (+4 to +9) of the initiation ATG codon. Left panel shows
the nucleotide distribution around the ATG of 119 ORFs classified as early. Rigth panel was derived from the sequence of late ge-
nes, excluding those containing the sequence TAAATG at the precise beginning.
amount of LacZ mRNA by quantitative RT-PCR
(Fig. 3B). Slight differences (±25%) were noted when
measured levels for the mutants were compared to that
of the control VV-Lz2 virus. Therefore, the mutations
–3 and +4 with respect to the AUG did not seem to
affect significantly mRNA levels.
Expression of β-Gal by recombinant viruses
We next determined β-Gal levels in extracts prepared
from cells infected with the different viruses at 24 hpi.
Figure 4 shows the β-Gal activity relative to that of
control VV-Lz2 virus from four independent experiments.
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Figure 2. Isolation of recombinant viruses with mutations in the ATG context. A) Sequence of oligonucleotides used for mutage-
nesis around the initiator ATG. To introduce all the possible mutations in the positions –3 and +4 around the β-Gal ATG, two over-
lapping oligonucleotides were designed, that included a mixture of the four nucleotides in the positions subject to study. These oli-
gonucleotides were used to generate two overlapping PCR products that would carry the sixteen possibilities of nucleotides in these
positions. B) Isolation of recombinant virus with point mutations around the ATG initiator. The products carrying the mutations
were amplified by PCR and transfected in BSC-1 cells infected with vaccinia virus vRB12, a virus mutant deficient in F13L. Vi-
rus plaques were selected using the F13L selection system and β-Gal staining. Finally, plaque-purified virus clones were expan-
ded, and the different versions were selected by sequencing. Black circle indicates the position of the promoter and sequence pre-
ceding β-Gal initiator ATG. Hatched boxes represent the left and right flanks for recombination into the viral genome.
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Table 1. Collection of recombinant virus. The ATG context of LacZ gene is shown.
The point mutations around the ATG initiator (underlined) are marked in red
–3 +4
ATTTTTTTTTTTTGGAATATAAATAACTCGAGATGGATCCCGTCGTT VV-Lz2
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Small differences were noted between the different clones,
but these were within 30% of the average values. Signi-
ficantly, the values obtained with clone VV-β-Gal GG
were 40% lower than those of VV-Lz2 virus, that contains
the same sequence around the initiator AUG in β-Gal
gene. Therefore, we consider that most, if not all, the
differences detected in β-Gal activity between individual
clones is within the experimental error.
Since the β-Gal protein product is identical in all of
our constructs (except for the first amino acid, which
is not present in the wild-type enzyme), we assume that
the specific activity and stability of β-Gal is identical in
all cases. With this assumption, the amount of β-Gal rela-
tive to the amount of LacZ mRNA levels is a direct indica-
tion of the translation efficiency of the respective mRNAs.
Discussion
Translation initiation of most eukaryotic mRNAs
takes place after a preinitiation complex binds to the
5’cap, scans the mRNA in the 5’ to 3’direction, and finds
a particular AUG codon as the initiation site. Selection
of the correct initiation codon is influenced, at least
partially, by its flanking residues; in mammalian cells,
the core of the «Kozak» consensus is (G/A)CCAUGG,
where the A residue of the AUG is designated position
+1. The purine residue in –3 is considered the most
important flanking residue, followed by G in +4 (Kozak,
1987, 2002). In this study we have examined the effects
of mutations in those two key positions flanking a
vaccinia virus translation initiation ATG codon. For
this purpose, recombinant vaccinia viruses containing
all possible nucleotide substitutions in positions –3
and +4 were constructed. β-Gal gene was chosen as a
reporter gene to facilitate quantitation of gene expression
levels. Because of the experimental design used, the
results refer exclusively to vaccinia late mRNAs, since
although a combined early/late promoter was used to
direct β-Gal expression, only a late time point (i.e., 24
hpi) was used in the experiments.
We have found that, in our experimental system,
neither position signif icantly affected the levels of
β-Gal enzymatic activity present in infected cells. To
rule out possible transcriptional effects of the mutations,
mRNA levels were quantitated and shown to be similar
for all the virus recombinants used in the study. Therefore,
we have to conclude that in our recombinant viruses
overexpressing β-Gal, there is no major effect of the
nucleotides in positions –3 and +4 in the translation
efficiency of vaccinia mRNAs. However, analysis of



























































































Figure 3. Quantitation of LacZ mRNA. A) Northern blot. BHK-21 cells grown in T-75 flask were infected with the virus collec-
tion at a MOI of 3 pfu cell-1. At 24 hpi, cells were scraped from the plastic, pelleted and the total RNA was extracted. RNA was se-
parated by electrophoresis and transferred to a nylon membrane. The hybridization was performed with LacZ (top) or F17L (bot-
tom) specific probes labeled with digoxigenin. B) Quantitative RT-PCR. BSC-1 cells were infected at a MOI of 5 pfu cell-1 with
the virus collection, WR or VV-Lz2. At 24 hpi the cells were collected and the RNA was extracted with the Rneasy Mini Kit (Quia-
gen). A quantitative RT-PCR reaction was performed with the TaqMan One-Step RT-PCR Kit. Data are presented as the percenta-
ge of LacZ expression with respect to the positive control VV-Lz2, and are the mean results from three independent experiments.
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the ORFs in the genomic sequence of vaccinia showed
a preference for A in position –3 and G or A in position
+4, suggesting that those positions conform to the
Kozak consensus. One possible explanation for our
inability to show differences in expression due to muta-
tions in these positions is that the promoter used to
express the marker gene β-Gal is extremely strong
(Blasco and Moss, 1995; Chakrabarti et al., 1997). This
promoter was derived from a mutagenesis study 
of strong natural promoters to maximize promoter
strenght (Davison and Moss, 1989a, b). As a consequence,
saturation of the translation machinery with a specific
mRNA might have precluded the detection of differences
in mRNA translation.
An alternative explanation is that, in contrast to
uninfected cells, the AUG context in vaccinia virus late
genes does not affect translation efficiency. To date,
there is little information about how vaccinia infection
modifies the cellular translation machinery. It has been
long known that vaccinia virus infection produces a
dramatic inhibition on the synthesis of cellular proteins.
This «shut-off» of cellular protein synthesis may in
part result from the rapid turnover of mRNAs during
infection, leading to enrichment of viral mRNAs. In
fact, several hours after infection, viral transcripts account
for most of the mRNA in the cytoplasm of the infected
cell (Boone and Moss, 1978; Cooper and Moss, 1979).
In addition, direct effects on translation have been
assigned to virion proteins (Mbuy et al., 1982; Person-
Fernández and Beaud, 1986; Beaud et al., 1994), early
proteins (Beaud and Dru, 1980), or RNAs (Rosemond-
Hornbeak and Moss, 1975; Gershowitz and Moss, 1979).
Vaccinia late mRNAs are similar to cellular mRNAs
in several ways; they are capped and polyadenilated.
However, they contain unusual features like the presence
of a poly-A sequence in the 5’end of the mRNA (Patel
and Pickup, 1987; Ahn and Moss, 1989; Ink and Pickup,
1990). How the unique 5’ structure feature of vaccinia
late transcripts relate to the lack of relevance of the –3
and +4 positions is not known.
Vaccinia late promoters contain the motif TAAAT
(Hanggi et al., 1986; Davison and Moss, 1989b) which
in most cases is closely placed upstream of the initiation
codon. Many highly expressed late genes contain the
sequence TAAATG, where the TAAAT motif overlaps
the translation initiation codon. Of note, in this sequence
the –3 position (T) does not conform to the canonical
Kozak sequence, which reinforces the idea that vaccinia
highly expressed genes may not, in some instances,
follow the «–3» Kozak rule.
Our results indicate an unambiguous compliance of
key nucleotide positions in vaccinia genes with the
Kozak rules. However, these positions not always lead
to significant differences in gene expression. Further
studies will be necessary to test the hypothesis that
viral proteins and/or RNAs functionally modify the
cellular translation machinery.
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Figure 4. β-Galactosidase activity. A) BSC-1 cells were infec-
ted with the virus collection or positive control VVLz2 at a MOI
of 5 pfu cell-1. Cells were lysed at 24 hpi and the β-Gal activity
was determined using ONPG as substrate. β-Gal levels relati-
ve to those of the VVLz2 are represented as the average ± SD
from four independent experiments. B) Translation efficiency
of β-Gal mRNA. β-Gal activity levels were corrected with res-
pect to the levels of β-Gal mRNA of each one of the recombi-
nant clones. The values are represented as the percent of those
obtained with VV-Lz2. C) Average levels obtained from all the
recombinants regarding nucleotide positions –3 (left) or +4
(right). The values were obtained by averaging the values from
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